Skip to main content

CORRECTION article

Front. Oncol., 17 October 2024
Sec. Cancer Molecular Targets and Therapeutics
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1501235

Corrigendum: Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts

This article is a correction to:

  1. Radiosynthesis and in-vitro identification of a molecular probe 131 I-FAPI targeting cancer-associated fibroblasts

    1. Read original article
Yaxin Tian,Yaxin Tian1,2Yanghongyan JiangYanghongyan Jiang3Ping MaPing Ma1Xiaowei MaXiaowei Ma1Liang DuLiang Du1Fengkui WangFengkui Wang1Xiaodong YuXiaodong Yu1Qian Zhao*Qian Zhao1*
  • 1Department of Nuclear Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
  • 2School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China
  • 3Department of Nuclear Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

A Corrigendum on
Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts

By Tian Y, Jiang Y, Ma P, Ma X, Du L, Wang F, Yu X and Zhao Q (2024). Front. Oncol. 14:1442601. doi: 10.3389/fonc.2024.1442601

In the published article, there was an error in affiliation 3. Instead of “Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China”, it should be “Department of Nuclear Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cancer-associated fibroblasts, FAPI, molecular probe, 131I, identification

Citation: Tian Y, Jiang Y, Ma P, Ma X, Du L, Wang F, Yu X and Zhao Q (2024) Corrigendum: Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts. Front. Oncol. 14:1501235. doi: 10.3389/fonc.2024.1501235

Received: 24 September 2024; Accepted: 26 September 2024;
Published: 17 October 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Tian, Jiang, Ma, Ma, Du, Wang, Yu and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qian Zhao, Y2VjaWxpYV9oaEAxMjYuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.